Iclevia Kit
Product Images NDC 65862-865

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Iclevia (NDC 65862-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Levo Ethi Fig1)

Illustration showing a weekly medication schedule for Iclevia (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg. Two separate weekly grids with circular placeholders for days Sunday through Saturday, labeled Week 3 and Week 4 respectively, are presented to help organize daily tablet intake.*

FDA Label Image

Figure B (Levo Ethi Fig2)

Diagram labeled as Figure B showing a weekly calendar grid for a 28-day regimen with circles corresponding to days Sunday through Saturday across four weeks. The last seven circles in the bottom row are shaded, indicating inactive or placebo tablets in the Iclevia (Levonorgestrel and Ethinyl Estradiol) kit. The label also includes the active ingredients' names and dosage strength of 0.15 mg and 0.03 mg, respectively.*

FDA Label Image

Figure 3 (Levo Ethi Fig3)

A horizontal forest plot chart comparing odds ratios (OR), relative risks (RR), and hazard ratios (HR) from various studies on contraceptive use: Ever combined oral contraceptives (COC) vs. never use, and current COC use vs. never use. The chart displays effect estimates with confidence intervals for each study along the horizontal axis.*

FDA Label Image

Figure 4 (Levo Ethi Fig4)

A chart illustrating the relative effectiveness of various birth control methods, ranked from fewer to more pregnancies per 100 women in one year. It categorizes methods into groups such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (91 Tablets Carton))

Figure A shows a 28-day medication schedule for Iclevia (Levonorgestrel and Ethinyl Estradiol) tablets, indicating daily pill intake arranged by day of the week (Sunday through Saturday) across four weeks. Each day corresponds to a circle representing a tablet dose of 0.15 mg/0.03 mg. This layout visually guides users on the order and timing for tablet consumption within the kit.*

FDA Label Image

Package Label-principal Display Panel (0.15 mg/0.03 mg (91 Tablets Pouch))

Illustration showing a weekly dosage schedule for Iclevia (Levonorgestrel and Ethinyl Estradiol) tablets. It depicts five weeks of circles arranged horizontally by day (Sunday to Saturday) with the first four weeks having unfilled circles and the fifth week shaded, indicating different tablet types or dosing phases in the 21/7-day regimen.*

FDA Label Image

Levo Ethi Fig7

An instructional diagram showing a hand pointing to the first pill in a weekly row of circular tablet slots labeled Sunday through Saturday. The diagram represents a dosing schedule for Iclevia (Levonorgestrel and Ethinyl Estradiol) tablets, displaying four rows of seven tablet circles each, corresponding to four weeks of daily dosing.*

FDA Label Image

Levo Ethi Fig8

Label for Iclevia (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg, a human prescription drug kit by Aurobindo Pharma Limited. The label states the kit contains one extended-cycle wallet with 91 tablets: 84 white active tablets and 7 green inert tablets. It includes storage, usage, and safety information along with manufacturer and distributor details.*

FDA Label Image

Levo Ethi Fig9

Packaging label for Iclevia (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg, an oral contraceptive product by Aurobindo Pharma Limited. The label specifies the kit contains 3 extended-cycle wallets with 91 tablets each, including white and green tablets. It includes dosage instructions, storage info, and regulatory warnings, with branding and distribution details from Aurobindo Pharma USA.*

FDA Label Image

Structure1 (Levo Ethi Str1)

Chemical structure of Levonorgestrel shown with molecular formula C21H28O2 and molecular weight 312.4. The structure includes multiple carbon rings and hydroxyl groups, illustrating the steroid framework of this active pharmaceutical ingredient.*

FDA Label Image

Structure2 (Levo Ethi Str2)

Chemical structure of Ethinyl Estradiol shown with its molecular formula C20H24O2 and molecular weight 296.4. The black and white structural diagram depicts the arrangement of atoms and bonds typical for this active ingredient in pharmaceutical products.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.